Mei-Lang Kung

kaohsiung veterans general hospital

H指数:24

被引数:1,471

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

VMAT-based lattice radiotherapy for advanced bulky hepatocellular carcinoma within multimodality treatment: a consecutive feasibility series

基于容积旋转调强技术的格点放射治疗在多模式治疗中的高级别巨大肝癌的连续可行性研究系列

Clinical and Translational Radiation Oncology

IF2.7

2026-08-010

OAAI

Delivery of stromal-derived factor-1α via biocompatible gold nanoparticles promotes dendritic cells viability and migration (vol 628, 127298, 2021)

通过生物相容性金纳米颗粒递送基质衍生因子-1α促进树突状细胞的活力和迁移（卷628，127298，2021）

COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS

IF5.4

2026-06-010

PRE

Corrigendum to “Functional engineered mesenchymal stem cells with fibronectin‑gold composite coated catheters for vascular tissue regeneration” [Nanomed: Nanotechnol Biol Med 14 (2018) 699–711]

勘误：功能性工程化间充质干细胞与纤维连接蛋白-金复合涂层导管用于血管组织再生 [Nanomed: Nanotechnol Biol Med 14 (2018) 699–711]

Nanomedicine: Nanotechnology, Biology and Medicine

IF0

2026-05-280

PRE

Phenolic zingerone nanoparticles impede cell cycle progression to compete against human urothelial carcinoma

酚类姜辣素纳米颗粒通过抑制细胞周期进展来对抗人尿路上皮癌

Biomedicine & Pharmacotherapy

IF7.5

2025-10-210

OAAI

Hepatoma-Derived Growth Factor Promotes Liver Carcinogenesis by Inducing Phosphatase and Tensin Homolog Inactivation

LABORATORY INVESTIGATION

IF4.2

2025-06-010

PRE

Nanosized Ginger-Derived Phenolic Zingerone Obstructs Cell Cycle G2/M Progression and Initiates Apoptosis in Human Colorectal Cancer

纳米级姜源酚类姜烯酚阻碍人结直肠癌细胞周期G2/M期进程并诱导凋亡

Environmental Toxicology

IF3.2

2025-02-250

PRE

Phytoconstituent-derived zingerone nanoparticles disrupt the cell adhesion mechanism and suppress cell motility in melanoma B16F10 cells

JOURNAL OF BIOTECHNOLOGY

IF3.9

2024-09-010

PRE

Deficiency of ADAR2 ameliorates metabolic-associated fatty liver disease via AMPK signaling pathways in obese mice

COMMUNICATIONS BIOLOGY

IF5.1

2024-05-171

OAAI

ADAR2 deficiency ameliorates non-alcoholic fatty liver disease and muscle atrophy through modulating serum amyloid A1

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE

IF9.1

2024-03-271

HDGF stimulates liver tumorigenesis by enhancing reactive oxygen species generation in mitochondria

JOURNAL OF BIOLOGICAL CHEMISTRY

IF3.9

2023-11-013

OAAI

Leukocyte cell-derived chemotaxin 2 regulates epithelial-mesenchymal transition and cancer stemness in hepatocellular carcinoma

JOURNAL OF BIOLOGICAL CHEMISTRY

IF3.9

2022-10-019

OAAI

Phytochemically Derived Zingerone Nanoparticles Inhibit Cell Proliferation, Invasion and Metastasis in Human Oral Squamous Cell Carcinoma

BIOMEDICINES

IF3.9

2022-01-2910

OAAI

Metformin inhibits gastric cancer cell proliferation by regulation of a novel Loc100506691-CHAC1 axis

MOLECULAR THERAPY ONCOLYTICS

IF5.3

2021-09-0122

OAAI

Fluoxetine ameliorates high-fat diet-induced metabolic abnormalities partially via reduced adipose triglyceride lipase-mediated adipocyte lipolysis

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2021-09-0113

OAAI

Nanogold-Carried Graphene Oxide: Anti-Inflammation and Increased Differentiation Capacity of Mesenchymal Stem Cells

NANOMATERIALS

IF4.3

2021-08-1121

OAAI

Hepatoma-derived growth factor participates in concanavalin A-induced hepatitis

FASEB JOURNAL

IF4.2

2020-10-158

PREAI

The protoapigenone analog WYC0209 targets CD133+cells: A potential adjuvant agent against cancer stem cells in urothelial cancer therapy

TOXICOLOGY AND APPLIED PHARMACOLOGY

IF3.4

2020-09-014

PREAI

Enhanced Biocompatibility and Differentiation Capacity of Mesenchymal Stem Cells on Poly(dimethylsiloxane) by Topographically Patterned Dopamine

地形图案化多巴胺增强间充质干细胞在聚二甲基硅氧烷上的生物相容性和分化能力

ACS APPLIED MATERIALS & INTERFACES

IF8.2

2020-07-2219

PREAI

Hepatoma-derived growth factor participates in Helicobacter Pylori-induced neutrophils recruitment, gastritis and gastric carcinogenesis

ONCOGENE

IF7.3

2019-07-2234

PREAI

Delta-like 1 homologue promotes tumorigenesis and epithelial-mesenchymal transition of ovarian high-grade serous carcinoma through activation of Notch signaling

ONCOGENE

IF7.3

2019-01-0936

OAAI

Mei-Lang Kung

个人简介

教育背景

工作经历

荣誉奖项

研究方向